Search Results 501-510 of 16805 for Flutamide

  1. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R ...

  2. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

  3. ShortStop-HER2: 12 Months Vs. 6 Months Of HER2-targeted Medications For People With HER2+ Breast Cancer Who Had A Pathologic Complete Response After Chemotherapy Plus Trastuzumab - Mayo Clinic

    Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer ...

  4. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members ...

  5. Oncology (Medical) - Clinical trials

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  6. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of TGR-1202 both alone and in combination with ublituximab in the treatment of previously ...

  7. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  8. Fluconazole (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Fluconazole injection is used to treat serious fungal or yeast infections, including oropharyngeal candidiasis (thrush, oral thrush), ...

  9. Integrative medicine - Doctors & Departments - Mayo Clinic

    This type of medicine adds complementary and alternative medicine (CAM) practices to mainstream medicine.

  10. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...